D.E. Shaw & Co’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-56,036
| Closed | -$833K | – | 3389 |
|
|
2025
Q1 | $833K | Buy |
+56,036
| New | +$833K | ﹤0.01% | 2258 |
|
|
2024
Q4 | – | Sell |
-122,354
| Closed | -$1.74M | – | 3384 |
|
|
2024
Q3 | $1.74M | Buy |
+122,354
| New | +$1.74M | ﹤0.01% | 1865 |
|
|
2024
Q2 | – | Sell |
-354,299
| Closed | -$4.92M | – | 3462 |
|
|
2024
Q1 | $4.92M | Buy |
354,299
+139,342
| +65% | +$1.94M | ﹤0.01% | 1290 |
|
|
2023
Q4 | $3.07M | Sell |
214,957
-52,938
| -20% | -$755K | ﹤0.01% | 1508 |
|
|
2023
Q3 | $4.14M | Sell |
267,895
-19,224
| -7% | -$297K | ﹤0.01% | 1291 |
|
|
2023
Q2 | $4.51M | Sell |
287,119
-123,295
| -30% | -$1.94M | ﹤0.01% | 1285 |
|
|
2023
Q1 | $6.76M | Buy |
+410,414
| New | +$6.76M | 0.01% | 1161 |
|
|
2022
Q2 | – | Sell |
-237,726
| Closed | -$3.4M | – | 4446 |
|
|
2022
Q1 | $3.4M | Buy |
237,726
+47,415
| +25% | +$679K | ﹤0.01% | 2022 |
|
|
2021
Q4 | $2.59M | Buy |
+190,311
| New | +$2.59M | ﹤0.01% | 2218 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3190 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 2890 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 2778 |
|
|
2020
Q2 | – | Sell |
-200,080
| Closed | -$3.04M | – | 2829 |
|
|
2020
Q1 | $3.04M | Sell |
200,080
-340,536
| -63% | -$5.17M | ﹤0.01% | 1308 |
|
|
2019
Q4 | $10.7M | Sell |
540,616
-1,465,417
| -73% | -$28.9M | 0.01% | 813 |
|
|
2019
Q3 | $34.5M | Buy |
2,006,033
+799,967
| +66% | +$13.8M | 0.04% | 392 |
|
|
2019
Q2 | $21.3M | Buy |
1,206,066
+886,083
| +277% | +$15.7M | 0.03% | 558 |
|
|
2019
Q1 | $6.52M | Buy |
+319,983
| New | +$6.52M | 0.01% | 1034 |
|